UHT — Universal Health Realty Income Trust stock price, charts and financials
QT50Universal Health Realty Income TrustUniversal Health Realty Income Trust (NYSE: UHT) is a Real Estate company in the REIT - Healthcare Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 31.01 | EPS (ttm) | 1.40 | Insider Own | 3.18% | Shs Outstand | 13.88M | Perf Week | -0.94% |
| Market Cap | 602.48M | Forward P/E | 23.86 | EPS next Y | 1.82 | Insider Trans | 0.00% | Shs Float | 12.76M | Perf Month | -3.47% |
| Enterprise Value | 990.76M | PEG | 4.51 | EPS next Q | - | Inst Own | - | Short Float | 2.95% | Perf Quarter | 6.68% |
| Income | 19.34M | P/S | 4.05 | EPS this Y | 34.11% | Inst Trans | - | Short Ratio | 2.50 | Perf Half Y | 11.36% |
| Sales | 148.78M | P/B | 4.17 | EPS next Y | 5.20% | ROA | 3.40% | Short Interest | 376.77K | Perf YTD | 10.74% |
| Book/sh | - | P/C | 12.15 | EPS next 5Y | 5.13% | ROE | 12.79% | 52W High | 45.45 -6.22% | Perf Year | 12.08% |
| Cash/sh | - | P/FCF | 12.19 | EPS past 3/5Y | -6.02% -2.07% | ROIC | 151.76% | 52W Low | 34.61 23.14% | Perf 3Y | -8.61% |
| Dividend Est. | 3.00 (7.04%) | EV/EBITDA | 15.19 | Sales past 3/5Y | 2.85% 4.88% | Gross Margin | 76.10% | Volatility | 2.65% 2.46% | Perf 5Y | -28.63% |
| Dividend TTM | 2.98 (6.99%) | EV/Sales | 6.66 | EPS Y/Y TTM | -7.19% | Oper. Margin | 36.46% | ATR (14) | 1.15 | Perf 10Y | -26.91% |
| Dividend Ex-Date | Jun 22, 2026 | Quick Ratio | 0.00 | Sales Y/Y TTM | 50.51% | Profit Margin | 12.95% | RSI (14) | 50.88 | Recom | 3.00 |
| Dividend Gr. 3/5Y | 1.39% 1.41% | Current Ratio | 0.00 | EPS Q/Q | -58.14% | SMA20 | -0.63% | Beta | 0.85 | Target Price | - |
| Payout | 213.76% | Debt/Eq | 2.75 | Sales Q/Q | 0.00% | SMA50 | 2.89% | Rel Volume | 0.50 | Prev Close | 43.42 |
| Employees | - | LT Debt/Eq | 2.53 | Earnings | Oct 26 | SMA200 | 5.89% | Avg Volume | 155.28K | Price | 42.62 |
| IPO Date | Dec 26, 1986 | Option/Short | Yes / Yes | EPS/Sales Surpr. | - -0.69% | Net Debt/EBITDA | 5.95 | Volume | 77,549 | Change | -1.84% |
Universal Health Realty Income Trust (UHT) operates as a real estate investment trust (REIT) dedicated to investing in properties within the healthcare and human services industries. Its portfolio is diverse, encompassing a range of facilities such as acute care hospitals, rehabilitation centers, sub-acute care facilities, medical office buildings, freestanding emergency departments, and childcare centers. The trust currently holds 71 properties across 20 U.S. states, two of which are actively under construction.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 149 | 99 | 99 | 96 | 91 | 84 | 78 | 77 | 76 | |
| Cost of Goods Sold Incl. D&A | 35 | 6 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | |
| Gross Profit | 113 | 94 | 94 | 90 | 86 | 80 | 74 | 73 | 72 | |
| Selling, General and Administrative Excl. Other | 2 | 0 | 0 | 0 | 0 | 0 | 4 | 4 | 4 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 56 | 59 | 57 | 59 | 55 | 51 | 44 | 43 | 42 | |
| Operating Income | 54 | 35 | 37 | 31 | 31 | 29 | 26 | 26 | 27 | |
| Interest Expense | 28 | 22 | 24 | 22 | 11 | 9 | 8 | 11 | 10 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -8 | 5 | 6 | 6 | 1 | 89 | 2 | 4 | 7 | |
| Net Income Before Taxes | 19 | 18 | 19 | 15 | 21 | 109 | 19 | 19 | 24 | |
| Income Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Consolidated Net Income | 19 | 18 | 19 | 15 | 21 | 109 | 19 | 19 | 24 | |
| Net Income From Continuing Operations | 19 | 18 | 19 | 15 | 21 | 109 | 19 | 19 | 24 | |
| Net Income | 19 | 18 | 19 | 15 | 21 | 109 | 19 | 19 | 24 | |
| EPS (Recurring) | 1.40 | 1.27 | 1.39 | 1.12 | 1.53 | 7.94 | 1.42 | 1.38 | 1.76 | |
| EPS (Basic, Before Extraordinaries) | 1.40 | 1.27 | 1.39 | 1.12 | 1.53 | 7.94 | 1.42 | 1.38 | 1.76 | |
| EPS (Diluted) | 1.40 | 1.27 | 1.39 | 1.11 | 1.53 | 7.92 | 1.41 | 1.38 | 1.76 | |
| EBITDA | 64 | 68 | 70 | 65 | 58 | 145 | 53 | 55 | 59 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 30.44 | 30.87 | 26.77 | 38.96 | 31.20 | 7.51 | 45.58 | 85.04 | 34.87 | |
| Price To Sales Ratio | 4.00 | 5.54 | 5.26 | 6.31 | 7.34 | 9.91 | 11.54 | 21.34 | 11.31 | |
| Gross Margin | 75.84 | 94.95 | 94.95 | 93.75 | 94.51 | 95.24 | 94.87 | 94.81 | 94.74 | |
| Operating Margin | 36.24 | 35.35 | 37.37 | 32.29 | 34.07 | 34.52 | 33.33 | 33.77 | 35.53 | |
| Net Margin | 12.75 | 18.18 | 19.19 | 15.63 | 23.08 | 129.76 | 24.36 | 24.68 | 31.58 | |
| Shares Outstanding | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | |
| Market Capitalization | 597 | 549 | 521 | 606 | 668 | 833 | 900 | 1,643 | 859 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| MILLER ALAN B | President, and CEO | Oct 29 '25 | Buy | 37.02 | 12,247 | 453,405 | 182,104 | Oct 30 |
| McCadden Robert F | Director | May 09 '24 | Buy | 37.38 | 2,000 | 74,760 | 11,644 | May 09 |
| MILLER ALAN B | President, and CEO | Apr 26 '24 | Buy | 34.65 | 6,000 | 207,881 | 157,753 | Apr 26 |
| MILLER ALAN B | President, and CEO | May 03 '23 | Buy | 43.18 | 2,395 | 103,414 | 147,141 | May 03 |
| McCadden Robert F | Director | Mar 10 '23 | Buy | 48.12 | 1,000 | 48,123 | 9,046 | Mar 10 |
| MILLER ALAN B | President, and CEO | Mar 07 '23 | Buy | 48.81 | 2,000 | 97,618 | 144,746 | Mar 08 |
| MILLER ALAN B | President, and CEO | Sep 14 '22 | Buy | 48.32 | 2,000 | 96,634 | 142,746 | Sep 15 |
| MILLER ALAN B | President, and CEO | Sep 08 '22 | Buy | 48.90 | 2,000 | 97,801 | 140,746 | Sep 09 |
| McCadden Robert F | Director | May 11 '22 | Buy | 47.81 | 500 | 23,903 | 7,500 | May 12 |
| McCadden Robert F | director: | May 10 '22 | Buy | 47.88 | 2,000 | 95,760 | 7,000 | May 12 |
| Domb Michael Allan | Director | Sep 10 '21 | Buy | 56.25 | 2,800 | 157,500 | 9,600 | Sep 10 |
| Domb Michael Allan | Director | Sep 09 '21 | Buy | 56.15 | 3,000 | 168,450 | 6,800 | Sep 10 |
| MILLER ALAN B | President, and CEO | Aug 17 '21 | Buy | 57.16 | 4,500 | 257,206 | 134,655 | Aug 18 |
| Domb Michael Allan | Director | Sep 10 '20 | Buy | 66.00 | 2,200 | 145,200 | 3,400 | Sep 10 |
| MILLER ALAN B | President, and CEO | Jul 30 '20 | Buy | 68.31 | 1,500 | 102,468 | 127,105 | Jul 31 |